TRCK · Track Group, Inc. · Insider Trading

This Form 4 is filed jointly by JCP Investment Partnership, LP ("JCP Partnership"), JCP Investment Partners, LP ("JCP Partners"), JCP Investment Holdings, LLC ("JCP Holdings"), JCP Investment Management, LLC ("JCP Management") and James C. Pappas (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

On September 30, 2026, JCP Management, on behalf of a JCP Account, entered into a securities purchase agreement pursuant to which it agreed to purchase certain securities of the Issuer. This transaction is expected to close in the near future.

Represents securities of the Issuer held in certain accounts managed by JCP Management (the "JCP Accounts"). JCP Management, as the investment manager of the JCP Accounts, may be deemed to beneficially own the securities held in the JCP Accounts. Mr. Pappas, as the managing member of JCP Management, may be deemed to beneficially own the securities held in the JCP Accounts.

Represents an award of restricted stock, of which 65,000 shares vest on each of April 30, 2027, April 30, 2028, April 30, 2029, April 30, 2030 and April 30, 2031.

Represents an award of restricted stock, of which 65,000 shares vest on each of April 30, 2027, April 30, 2028, April 30, 2029, April 30, 2030 and April 30, 2031.

This Form 4 is filed jointly by CRC Founders Fund, LP ("CRC Founders"), Carlson Ridge Capital, LLC ("Carlson Ridge Capital"), Carlson Ridge Capital GP, LLC ("Carlson Ridge GP") and Denver J. Smith (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Mr. Smith is also a director of the Issuer. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

Represents an award of restricted stock, of which 65,000 shares vest on each of April 30, 2027, April 30, 2028, April 30, 2029, April 30, 2030 and April 30, 2031.

Represents grant of restricted stock. Shares shall vest 1/5 on April 30, 2027, 1/5 on April 30, 2028, 1/5 on April 30, 2029, 1/5 on April 30, 2030 and 1/5 on April 30, 2031.

This amendment to the Form 4 originally filed on August 24, 2026 is being filed solely to correct the number of shares of restricted stock granted to the reporting person.

Represents grant of restricted stock. Shares shall vest 1/5 on April 30, 2027, 1/5 on April 30, 2028, 1/5 on April 30, 2029, 1/5 on April 30, 2030 and 1/5 on April 30, 2031.

Represents an award of restricted stock, of which 65,000 shares vest on each of April 30, 2027, April 30, 2028, April 30, 2029, April 30, 2030 and April 30, 2031.

Represents grant of restricted stock. Shares shall vest 1/5 on April 30, 2027, 1/5 on April 30, 2028, 1/5 on April 30, 2029, 1/5 on April 30, 2030 and 1/5 on April 30, 2031.

This Form 4 is filed jointly by CRC Founders Fund, LP ("CRC Founders"), Carlson Ridge Capital, LLC ("Carlson Ridge Capital"), Carlson Ridge Capital GP, LLC ("Carlson Ridge GP") and Denver J. Smith (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Mr. Smith is also a director of the Issuer. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

Represents an award of restricted stock, of which 65,000 shares vest on each of April 30, 2027, April 30, 2028, April 30, 2029, April 30, 2030 and April 30, 2031.

Represents grant of restricted stock. Shares shall vest 1/5 on April 30, 2027, 1/5 on April 30, 2028, 1/5 on April 30, 2029, 1/5 on April 30, 2030 and 1/5 on April 30, 2031.

This amendment to the Form 4 originally filed on August 24, 2026 is being filed solely to correct the number of shares of restricted stock granted to the reporting person.

Represents an award of restricted stock, of which 65,000 shares vest on each of April 30, 2027, April 30, 2028, April 30, 2029, April 30, 2030 and April 30, 2031.

Represents grant of restricted stock. Shares shall vest 1/5 on April 30, 2027, 1/5 on April 30, 2028, 1/5 on April 30, 2029, 1/5 on April 30, 2030 and 1/5 on April 30, 2031.

Represents shares of common stock (the "Shares") purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated April 30, 2026 (the "Private Placement"). The issuance of the Shares to the reporting person pursuant to the Private Placement was approved by the Company's board of directors and was deemed an exempt transaction pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").

Represents shares of common stock (the "Shares") purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated April 30, 2026 (the "Private Placement"). The issuance of the Shares to the reporting person pursuant to the Private Placement was approved by the Company's board of directors and was deemed an exempt transaction pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").

Represents shares of common stock (the "Shares") purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated April 30, 2026 (the "Private Placement"). The issuance of the Shares to the reporting person pursuant to the Private Placement was approved by the Company's board of directors and was deemed an exempt transaction pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").

The shares were purchased in a private transaction pursuant to a share purchase agreement dated March 4, 2024, by and between the Reporting Person and an existing shareholder of the Issuer.

Represents grant of restricted stock. Shares shall vest 1/3 on October 13, 2022, 1/3 on April 13, 2023 and 1/3 on October 13, 2023.

50% of the stock options vested on January 1, 2018, with the remainder vesting on January 1, 2019.